• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

进化机制统一了癌症的特征。

Evolutionary mechanism unifies the hallmarks of cancer.

作者信息

Horne Steven D, Pollick Sarah A, Heng Henry H Q

机构信息

Center for Molecular Medicine and Genetics, Wayne State University School of Medicine, Detroit, MI.

出版信息

Int J Cancer. 2015 May 1;136(9):2012-21. doi: 10.1002/ijc.29031. Epub 2014 Jun 30.

DOI:10.1002/ijc.29031
PMID:24957955
Abstract

The basis for the gene mutation theory of cancer that dominates current molecular cancer research consists of: the belief that gene-level aberrations such as mutations are the main cause of cancers, the concept that stepwise gene mutation accumulation drives cancer progression, and the hallmarks of cancer. The research community swiftly embraced the hallmarks of cancer, as such synthesis has supported the notions that common cancer genes are responsible for the majority of cancers and the complexity of cancer can be dissected into simplified molecular principles. The gene/pathway classification based on individual hallmarks provides explanation for the large number of diverse gene mutations, which is in contrast to the original estimation that only a handful of gene mutations would be discovered. Further, these hallmarks have been highly influential as they also provide the rationale and research direction for continued gene-based cancer research. While the molecular knowledge of these hallmarks is drastically increasing, the clinical implication remains limited, as cancer dynamics cannot be summarized by a few isolated/fixed molecular principles. Furthermore, the highly heterogeneous genetic signature of cancers, including massive stochastic genome alterations, challenges the utility of continuously studying each individual gene mutation under the framework of these hallmarks. It is therefore necessary to re-evaluate the concept of cancer hallmarks through the lens of cancer evolution. In this analysis, the evolutionary basis for the hallmarks of cancer will be discussed and the evolutionary mechanism of cancer suggested by the genome theory will be employed to unify the diverse molecular mechanisms of cancer.

摘要

主导当前分子癌症研究的癌症基因突变理论的基础包括

认为诸如突变等基因水平的畸变是癌症的主要原因,逐步积累基因突变驱动癌症进展的概念,以及癌症的特征。研究界迅速接受了癌症的特征,因为这样的综合支持了以下观点:常见的癌症基因导致了大多数癌症,并且癌症的复杂性可以分解为简化的分子原理。基于各个特征的基因/通路分类为大量不同的基因突变提供了解释,这与最初认为只会发现少数基因突变的估计形成了对比。此外,这些特征具有很大的影响力,因为它们也为持续的基于基因的癌症研究提供了理论依据和研究方向。虽然对这些特征的分子认识正在急剧增加,但临床意义仍然有限,因为癌症动态不能用一些孤立/固定的分子原理来概括。此外,癌症高度异质的基因特征,包括大量随机的基因组改变,挑战了在这些特征框架下持续研究每个个体基因突变的实用性。因此,有必要通过癌症进化的视角重新评估癌症特征的概念。在本分析中,将讨论癌症特征的进化基础,并采用基因组理论提出的癌症进化机制来统一癌症的各种分子机制。

相似文献

1
Evolutionary mechanism unifies the hallmarks of cancer.进化机制统一了癌症的特征。
Int J Cancer. 2015 May 1;136(9):2012-21. doi: 10.1002/ijc.29031. Epub 2014 Jun 30.
2
Predictive genomics: a cancer hallmark network framework for predicting tumor clinical phenotypes using genome sequencing data.预测基因组学:使用基因组测序数据预测肿瘤临床表型的癌症标志网络框架。
Semin Cancer Biol. 2015 Feb;30:4-12. doi: 10.1016/j.semcancer.2014.04.002. Epub 2014 Apr 18.
3
The evolutionary mechanism of cancer.癌症的进化机制。
J Cell Biochem. 2010 Apr 15;109(6):1072-84. doi: 10.1002/jcb.22497.
4
Micronuclei and Genome Chaos: Changing the System Inheritance.微核与基因组混沌:改变系统遗传。
Genes (Basel). 2019 May 13;10(5):366. doi: 10.3390/genes10050366.
5
Genetic and epigenetic heterogeneity in cancer: a genome-centric perspective.癌症中的遗传和表观遗传异质性:以基因组为中心的视角
J Cell Physiol. 2009 Sep;220(3):538-47. doi: 10.1002/jcp.21799.
6
Evolutionary mechanisms and diversity in cancer.癌症中的进化机制和多样性。
Adv Cancer Res. 2011;112:217-53. doi: 10.1016/B978-0-12-387688-1.00008-9.
7
Genome chaos: Creating new genomic information essential for cancer macroevolution.基因组混乱:创造癌症大进化所必需的新基因组信息。
Semin Cancer Biol. 2022 Jun;81:160-175. doi: 10.1016/j.semcancer.2020.11.003. Epub 2020 Nov 13.
8
Chromosomal instability (CIN): what it is and why it is crucial to cancer evolution.染色体不稳定性(CIN):它是什么以及为何对癌症演变至关重要。
Cancer Metastasis Rev. 2013 Dec;32(3-4):325-40. doi: 10.1007/s10555-013-9427-7.
9
Cancer genome sequencing: the challenges ahead.癌症基因组测序:未来的挑战。
Bioessays. 2007 Aug;29(8):783-94. doi: 10.1002/bies.20610.
10
The dynamics of cancer chromosomes and genomes.癌症染色体与基因组的动态变化
Cytogenet Genome Res. 2007;118(2-4):237-46. doi: 10.1159/000108306.

引用本文的文献

1
Evolution of the module for phloem development in angiosperms.被子植物韧皮部发育模块的演化
Proc Natl Acad Sci U S A. 2025 Mar 11;122(10):e2416674122. doi: 10.1073/pnas.2416674122. Epub 2025 Mar 7.
2
The evolutionary cancer genome theory and its reasoning.进化癌症基因组理论及其推理。
Genet Med Open. 2023 Apr 23;1(1):100809. doi: 10.1016/j.gimo.2023.100809. eCollection 2023.
3
Life history dynamics of evolving tumors: insights into task specialization, trade-offs, and tumor heterogeneity.进化肿瘤的生活史动态:对任务专业化、权衡和肿瘤异质性的见解。
Cancer Cell Int. 2024 Nov 6;24(1):364. doi: 10.1186/s12935-024-03538-4.
4
Editorial for the Special Issue "Latest Review Papers in Molecular Oncology 2023".专刊编辑按语:“2023 年分子肿瘤学最新综述论文”专刊
Int J Mol Sci. 2024 Mar 13;25(6):3257. doi: 10.3390/ijms25063257.
5
Systematic pharmacology-based strategy to explore the mechanism of Semen Strychni for treatment of papillary thyroid carcinoma.基于系统药理学的策略探索马钱子治疗甲状腺乳头状癌的机制。
Sci Rep. 2023 Oct 28;13(1):18492. doi: 10.1038/s41598-023-45741-9.
6
Regulation of Cell Plasticity by Bromodomain and Extraterminal Domain (BET) Proteins: A New Perspective in Glioblastoma Therapy.Bromodomain 和 Extraterminal 结构域(BET)蛋白对细胞可塑性的调控:胶质母细胞瘤治疗的新视角。
Int J Mol Sci. 2023 Mar 16;24(6):5665. doi: 10.3390/ijms24065665.
7
The Revelation of Continuously Organized, Co-Overexpressed Protein-Coding Genes with Roles in Cellular Communications in Breast Cancer.乳腺癌中细胞通讯相关的连续组织、协同过表达的蛋白编码基因的揭示。
Cells. 2022 Nov 28;11(23):3806. doi: 10.3390/cells11233806.
8
Immunohistochemical Expression of p62 in Feline Mammary Carcinoma and Non-Neoplastic Mammary Tissue.p62在猫乳腺癌及非肿瘤性乳腺组织中的免疫组化表达
Animals (Basel). 2022 Aug 2;12(15):1964. doi: 10.3390/ani12151964.
9
How to conjugate the stemness marker ALDH1A1 with tumor angiogenesis, progression, and drug resistance.干性标志物醛脱氢酶1家族成员A1(ALDH1A1)如何与肿瘤血管生成、进展及耐药性相关联。
Cancer Drug Resist. 2020 Mar 19;3(1):26-37. doi: 10.20517/cdr.2019.70. eCollection 2020.
10
mutation and Ras/Raf/MAPK activation confer acquired resistance to EGFR tyrosine kinase inhibitor in an EGFR mutated NSCLC cell line.在一种EGFR突变的非小细胞肺癌细胞系中,突变和Ras/Raf/丝裂原活化蛋白激酶(MAPK)激活赋予了对EGFR酪氨酸激酶抑制剂的获得性耐药。
Transl Cancer Res. 2020 Apr;9(4):2542-2555. doi: 10.21037/tcr.2020.03.05.